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PURPOSE: Depression has a profound influence on patients’ reporting of seizure severity (SS) and is a po-
tential confounder when evaluating the relationship between SS and quality of life (QoL). Women with ep-
ilepsy are a specific subpopulation at risk of developing comorbid depression in consequence of complica-
tions of pregnancy or motherhood due to epilepsy and antiepileptic drug (AED) treatment. Aim of the pres-
ent study was to explore the relationship between SS and QOL aspects in 82 women while controlling for de-
pression.
MATERIAL AND METHODS: All the women underwent clinical psychiatric examination for detecting co-
morbid depressive disorder (DD) according to the International Statistical Classification of Diseases and 
Related Health Problems, 110th Revision  (ICD-10) diagnostic criteria. Evaluation on Hamilton Depression 
Rating Scale (HAM-D-17) supported the diagnosis. SS and QOL were measured by self-assessment scales 
such as Seizure Severity Questionnaire (SSQ) and Quality of Life in Epilepsy Inventory-31 (QOLIE-31). Data 
processing and analysis were carried out using SPSS for Windows (Version 15.0). Statistical analyses includ-
ed Student’s t-test, Pearson’s correlation and multivariate linear regression.
RESULTS: SS correlated highly significantly with all QOLIE-31 domains’ scores except medication effects’ 
score. There was a strong correlation between SS and seizure worry (r=-0,766; p<0,001) and a moderate be-
tween SS and social function (r=- 0,590: p< 0,001) and SS and overall quality of life (r=-0,534; p<0,001). 
When the effect of depression was controlled for, SS regression remained significant for seizure worry 
(R²=0,580; p<0,001) and overall QoL (R²=0,603; p=0,03). 
CONCLUSION: Our results show that severe and potentially injurious seizures contribute to high levels of 
anxiety and reduce the QoL of patients with epilepsy raising questions about comorbid DD. Given the great 
prevalence of the psychiatric disorders in patients with epilepsy neurologists must incorporate the essen-
tials of their diagnosis and management into routine clinical practice which will improve patient’s QoL.
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INTRODUCTION
Quality of life (QoL) is of major importance 
when assessing the impact and treatment of epilepsy 
and comprises various components. Some of them 
such as physical areas can be measured objectively 
opposite to the psychosocial ones which are mainly 
subjective in nature (10). 
Being an important seizure-related variable, 
seizure severity (SS) is a major aspect of QoL in 
epilepsy, however, the relationship between SS and 
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QOL has been incompletely explored yet. On the 
other hand, when present in epilepsy, comorbid 
depressive disorder (DD) is a powerful predictor 
of QoL, sometimes exerting even a stronger effect 
than other clinical variables (2). Comorbid DD 
has a profound influence on patients’ reporting 
of SS. Clinically depressed people with epilepsy 
report higher levels of all aspects of SS and bother 
from seizures, as well as increased difficulties with 
overall seizure recovery when compared with a non-
depressed epilepsy control group (6). As depression 
impacts the reporting of SS as well as QoL in epilepsy 
it is a potential confounder when evaluating the 
relationship between them. Women with epilepsy 
are a specific subpopulation at risk of developing 
comorbid DD in consequence of complications 
of pregnancy or motherhood due to epilepsy and 
antiepileptic drug (AED) treatment (1,8,14). 
Our aim was to examine the relationship 
between SS and QoL aspects in women with epilepsy 
while controlling for depression.
MATERIAL AND METHODS
Participants were 82 women aged 18-55 
years with diagnosis of epilepsy as defined in the 
classification of seizures of the International league 
against epilepsy (3). Excluded of the sample were 
all the patients with a progressive structural brain 
abnormality documented by computed tomography 
or magnetic resonance imaging, mental retardation 
as defined by the International Classification of 
Diseases, Version 10 (ICD-10) diagnostic criteria 
(15), severe comorbid somatic disease or comorbid 
psychiatric condition excluding affective disorders, 
presence of psychogenic seizures or syncopes as well 
as generalized tonic-clonic seizures within 24 hours 
of the evaluation, or partial ones within 6 hours of 
the evaluation. 
All the female patients underwent clinical 
psychiatric examination for detecting comorbid DD 
according to ICD-10 diagnostic criteria. Evaluation 
on Hamilton Depression Rating Scale (HAM-
D-17) supported the diagnosis (9). SS and QoL were 
measured by self-assessment scales such as Seizure 
Severity Questionnaire (SSQ) and Quality of Life 
in Epilepsy Inventory-31 (QOLIE-31) (4,5). These 
assessment scales were translated into Bulgarian 
according to the basic guidelines for translating 
surveys and assessed for validity and reliability (11). 
Data processing and analysis were carried out 
using SPSS for Windows (Version 15.0). Student’s t-
test was used for comparing SS scores by depression 
grouping while Pearson correlation was applied for 
evaluating the effect of SS on QOLIE-31 domains and 
HAM-D-17 scores. Multivariate linear regression 
was performed for assessing the independent effect 
of SS on QoL domains after controlling for mood 
scores. Any p-values were two-sided with statistical 
significance evaluated at α=0,05 level. Ninety-five 
percent confidence intervals (95% CI) were also 
calculated to assess the precision of β-values obtained.
HAM-D-17 is a 17-item questionnaire exploring 
10 domains associated with depression: mood, 
anxiety, sexual function, appetite, sleep, functional 
status, physical symptoms, hypochondriasis, 
diurnal variation and general psychiatric distress. 
To quantify symptom severity, for each item, a 
score is devised ranging from 0 (normal) to 2 or 4 
(maximal impairment) (5). Based on HAM-D-17 
scores, depression was defined as mild (7-17 points), 
moderate (18-24 points) and severe (>24 points). 
SSQ is included as a self-report assessment which 
categorizes seizures into three phases: warning, ictal 
activity and postictal recovery. The recovery phase is 
subdivided into three components such as cognitive, 
emotional and physical aspects of recovery, each 
rated for frequency, severity and bothersomeness. 
QOLIE-31 includes seven subscales: overall QoL, 
seizure worry, emotional well-being, energy/fatigue, 
cognitive function, medication effects and social 
function. The responses can yield seven individual 
scores (per subtests) and an overall (composite) score. 
The higher scores indicate a better QoL.
RESULTS
SS scores of both groups of women, with 
epilepsy only and with epilepsy and comorbid 
DD, are presented on Table 1. Clinically depressed 
women with epilepsy reported significantly higher 
levels of SS scores (t=2,06; p<0,05) compared to those 
with epilepsy only and  significantly lower QOLIE-31 
overall  and subscale scores for all domains except 
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medication effects and cognitive function (Table 2). 
There was a significant correlation between SS and 
all QOLIE-31 domains’ scores except medication 
effects score. The correlation was strong for seizure 
worry and medium for the other subscales (Table 3). 
A medium correlation was detected between SS and 
comorbid depression (r=0,40; p<0,001). When the 
confounding effect of depression was controlled for, 
SS regression remained significant for seizure worry 











Epilepsy with  
Depression
4,05 ±1,78
Tabl. 1. SS scores by depression grouping
QOLIE-31 Domains Epilepsy  with DD Epilepsy without DD t p
Social function 39,2 61,35 2,86 < 0,01
Medication effects 35,97 45,98 1,17 > 0,05
Cognitive function 47,89 58,45 1,78 > 0,05
Energy/Fatigue 41,75 61,11 4,22 < 0,001
Emotional well-being 39,6 61,82 5,55 < 0,001
Overall QoL 44,37 62,27 3,47 < 0,001
Seizure worry 32,96 50,33 2,31 < 0,05
Tabl.2. QOLIE-31 scores according to comorbidity of Epilepsy and DD
Variable  Pearson correlation coefficient p D
Seizure worry -0,766 < 0,001 58,67%
Overall QoL -0,534 < 0,001 28,52%
Emotional well-being -0,484 < 0,001 23,52%
Energy/Fatigue -0,464 < 0,001 21,53%
Cognitive functioning -0,418 < 0,001 17,47%
Medication effects -0,151 > 0,05 2,28%
Social functioning -0,59 < 0,001 34,81%
HAM-D-17 scores 0,409 < 0,001 16,73%
Tabl. 3. Correlation between SS, QOLIE-31 scores and HAM-D-17 scores






Seizure worry -0,043 -0,666 0,001 0,58
Overall QoL -0,018 -0,199 0,037 0,603
Tabl. 4. Multiple linear regression (controlling for HAM-D-17 scores) between SS and  QOLIE-31 domains  
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Our results suggest that there is an association 
between SS, comorbid DD and QoL in women 
with epilepsy. When controlling for depression the 
association of SS with QOL aspects such as seizure 
worry and individuals perspectives on their overall 
QoL remains significant. There is evidence that SS 
promotes the development or exacerbation of worry 
and anxiety in patients with epilepsy and changes 
perspectives on their overall QoL and yet the 
percentage of variance accounted for by SS regression 
with QoL indicated that multiple factors affect QoL 
in epilepsy (6,10) .
The association of SS with seizure worry 
implies a SS effect on anxiety, and anxiety itself 
has an important effect on QoL in women with 
epilepsy. Cramer et al. evaluate the differential 
effect of anxiety and depression on QoL in people 
with partial epilepsy and establish that anxiety is a 
strong predictor of QoL, contributing to one-third 
of the variance in scores (7). Harden et al. find out 
that two QOLIE-31 domains correlate significantly 
with SS in women with epilepsy: seizure worry and 
social function and controlling for depression still 
indicating that SS regression with QOLIE-31 seizure 
worry subscale remains significant (10). 
No significant association between the 
medication effects subscale of QOLIE-31 and SS 
was found out in our study thus suggesting that 
medication adverse effects were not any confounder 
in the association between SS and QoL in women 
with epilepsy. Similar results were reported by 
Harden et al., too (10).  Szaflarski et al. apply adverse 
event profile for evaluation of medication side 
effects and report significant correlation between 
the medication side effects and QoL in epilepsy (13). 
We suggest that interpreting the results obtained by 
different instruments should be taken into account. 
The directional relationship of the association 
between SS and comorbid depression has not been 
demonstrated in our study, and yet patients with 
epilepsy often report emotional stress as a seizure 
precipitant (12). It is a possibility that emotional 
stress could worsen SS as well as worsened SS 
could precipitate emotional stress and depressive 
symptoms. 
CONCLUSION
In epilepsy, QoL is a worthwhile concept that 
poses different types of questions. Although it has 
multiple determinants, symptoms of depression and 
seizure worry are among the most important factors 
affecting QoL in women with epilepsy of childbearing 
age. Further research of the complexity of the 
relationship between SS, psychiatric comorbidity and 
QoL in epilepsy should enlighten the matter.
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